MDS patient characteristics
| No. . | Age, y . | Sex . | IPSS . | Karyotype . |
|---|---|---|---|---|
| 275 | 74 | F | IR1 | 46XY, del(5) |
| 276 | 72 | M | LR | 46XY |
| 277 | 70 | M | IR1 | 46XY, del(11) |
| 278 | 66 | M | IR1 | 46XY |
| 279 | 65 | M | LR | 46XY |
| 280 | 67 | F | IR1 | 46XX, del(5)(q13;q33) |
| 281 | 59 | F | IR1 | 46XX |
| 283 | 73 | F | IR2 | 46XX, del(22)(q11) |
| 284 | 71 | M | HR | 46XY, del(11) |
| 285 | 70 | M | IR2 | 46XY |
| 286 | 58 | M | HR | 46XY |
| 3000* | 50 | F | LR | 46XX, del(5) |
| 3853* | 50 | M | IR2 | NA |
| 3883* | 55 | M | IR2 | 46XY |
| 3923* | 52 | F | IR2 | NA |
| 4015* | 71 | F | HR | 46XX, t(3;5) |
| 5050* | 70 | M | IR1 | 46XY |
| 5324* | 54 | M | IR2 | 44-46XY, −5, −7, −21, +8 |
| 13591* | 63 | F | IR1 | 46XX, del(5), +8, del(12) |
| No. . | Age, y . | Sex . | IPSS . | Karyotype . |
|---|---|---|---|---|
| 275 | 74 | F | IR1 | 46XY, del(5) |
| 276 | 72 | M | LR | 46XY |
| 277 | 70 | M | IR1 | 46XY, del(11) |
| 278 | 66 | M | IR1 | 46XY |
| 279 | 65 | M | LR | 46XY |
| 280 | 67 | F | IR1 | 46XX, del(5)(q13;q33) |
| 281 | 59 | F | IR1 | 46XX |
| 283 | 73 | F | IR2 | 46XX, del(22)(q11) |
| 284 | 71 | M | HR | 46XY, del(11) |
| 285 | 70 | M | IR2 | 46XY |
| 286 | 58 | M | HR | 46XY |
| 3000* | 50 | F | LR | 46XX, del(5) |
| 3853* | 50 | M | IR2 | NA |
| 3883* | 55 | M | IR2 | 46XY |
| 3923* | 52 | F | IR2 | NA |
| 4015* | 71 | F | HR | 46XX, t(3;5) |
| 5050* | 70 | M | IR1 | 46XY |
| 5324* | 54 | M | IR2 | 44-46XY, −5, −7, −21, +8 |
| 13591* | 63 | F | IR1 | 46XX, del(5), +8, del(12) |
No. indicates sample number; M, male; F, female; IR1, intermediate-1 risk; IR2, intermediate-2 risk; and NA, not available.
Nos. 277 and 284 are paired samples from the same patient.
Verification sample group.